; and (2) the date on which the Corporation receives the final payment for the sale of all rare disease therapeutics owned by the Corporation. 4. Definitions For purposes of this Act: (1) Accredited investor The term accredited investor has the meaning given such term under section 2(a) of the Securities Act of 1933 ( 15 U.S.C. 77b(a) ). (2) Corporation The term Corporation means the Rare Disease Therapeutics Corporation established under section 3(a). (3) Rare disease therapeutics The term rare disease therapeutics means a compound, biologic, medical device, or companion diagnostic that has been designated as a therapy for a rare disease or condition pursuant to section 526 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bb ). (4) Secretary The term Secretary means the Secretary of the Treasury. (5) Securities laws The term securities laws has the meaning given that term under section 3(a) of the Securities Exchange Act of 1934 ( 15 U.S.C. 78c(a) ).